Dyrk1A induces pancreatic β cell mass expansion and improves glucose tolerance

References

• Ferrannini E. The stunned beta cell: a brief history. Cell Metab 2010; 11:349 - 52; http://dx.doi.org/10.1016/j.cmet.2010.04.009; PMID: 20444416
   PubMed Web of Science ®Google Scholar
• Fotaki V, Dierssen M, Alcántara S, Martínez S, Martí E, Casas C, Visa J, Soriano E, Estivill X, Arbonés ML. Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice. Mol Cell Biol 2002; 22:6636 - 47; http://dx.doi.org/10.1128/MCB.22.18.6636-6647.2002; PMID: 12192061
   PubMed Web of Science ®Google Scholar
• Tejedor FJ, Hämmerle B. MNB/DYRK1A as a multiple regulator of neuronal development. FEBS J 2011; 278:223 - 35; http://dx.doi.org/10.1111/j.1742-4658.2010.07954.x; PMID: 21156027
   PubMed Web of Science ®Google Scholar
• Oegema R, de Klein A, Verkerk AJ, Schot R, Dumee B, Douben H, Eussen B, Dubbel L, Poddighe PJ, van der Laar I, et al. Distinctive Phenotypic Abnormalities Associated with Submicroscopic 21q22 Deletion Including DYRK1A. Mol Syndromol 2010; 1:113 - 20; PMID: 21031080
   PubMedGoogle Scholar
• Le Douarin NM. On the origin of pancreatic endocrine cells. Cell 1988; 53:169 - 71; http://dx.doi.org/10.1016/0092-8674(88)90375-3; PMID: 3282672
   PubMed Web of Science ®Google Scholar
• Atouf F, Czernichow P, Scharfmann R. Expression of neuronal traits in pancreatic beta cells. Implication of neuron-restrictive silencing factor/repressor element silencing transcription factor, a neuron-restrictive silencer. J Biol Chem 1997; 272:1929 - 34; http://dx.doi.org/10.1074/jbc.272.3.1929; PMID: 8999882
   PubMed Web of Science ®Google Scholar
• Rorsman P. The pancreatic beta-cell as a fuel sensor: an electrophysiologist’s viewpoint. Diabetologia 1997; 40:487 - 95; http://dx.doi.org/10.1007/s001250050706; PMID: 9165215
   PubMed Web of Science ®Google Scholar
• van Arensbergen J, García-Hurtado J, Moran I, Maestro MA, Xu X, Van de Casteele M, Skoudy AL, Palassini M, Heimberg H, Ferrer J. Derepression of Polycomb targets during pancreatic organogenesis allows insulin-producing beta-cells to adopt a neural gene activity program. Genome Res 2010; 20:722 - 32; http://dx.doi.org/10.1101/gr.101709.109; PMID: 20395405
   PubMed Web of Science ®Google Scholar
• Rachdi L, Kariyawasam D, Guez F, Aïello V, Arbonés ML, Janel N, Delabar J-M, Polak M, Scharfmann R. Dyrk1a haploinsufficiency induces diabetes in mice through decreased pancreatic beta cell mass. Diabetologia 2014; 57:960 - 9; http://dx.doi.org/10.1007/s00125-014-3174-3; PMID: 24477974
   PubMed Web of Science ®Google Scholar
• Rahier J, Guiot Y, Goebbels RM, Sempoux C, Henquin JC. Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 2008; 10:Suppl 4 32 - 42; http://dx.doi.org/10.1111/j.1463-1326.2008.00969.x; PMID: 18834431
   PubMed Web of Science ®Google Scholar
• Ashcroft FM, Rorsman P. Diabetes mellitus and the β cell: the last ten years. Cell 2012; 148:1160 - 71; http://dx.doi.org/10.1016/j.cell.2012.02.010; PMID: 22424227
   PubMed Web of Science ®Google Scholar
• Drucker DJ. Incretin action in the pancreas: potential promise, possible perils, and pathological pitfalls. Diabetes 2013; 62:3316 - 23; http://dx.doi.org/10.2337/db13-0822; PMID: 23818527
   PubMed Web of Science ®Google Scholar
• Guedj F, Pereira PL, Najas S, Barallobre M-J, Chabert C, Souchet B, Sebrie C, Verney C, Herault Y, Arbones M, et al. DYRK1A: a master regulatory protein controlling brain growth. Neurobiol Dis 2012; 46:190 - 203; http://dx.doi.org/10.1016/j.nbd.2012.01.007; PMID: 22293606
   PubMed Web of Science ®Google Scholar
• Thomazeau A, Lassalle O, Iafrati J, Souchet B, Guedj F, Janel N, Chavis P, Delabar J, Manzoni OJ. Prefrontal deficits in a murine model overexpressing the down syndrome candidate gene dyrk1a. J Neurosci 2014; 34:1138 - 47; http://dx.doi.org/10.1523/JNEUROSCI.2852-13.2014; PMID: 24453307
   PubMed Web of Science ®Google Scholar
• Laguna A, Barallobre M-J, Marchena M-Á, Mateus C, Ramírez E, Martínez-Cue C, Delabar JM, Castelo-Branco M, de la Villa P, Arbonés ML. Triplication of DYRK1A causes retinal structural and functional alterations in Down syndrome. Hum Mol Genet 2013; 22:2775 - 84; http://dx.doi.org/10.1093/hmg/ddt125; PMID: 23512985
   PubMed Web of Science ®Google Scholar
• Hong S-H, Lee K-S, Kwak S-J, Kim A-K, Bai H, Jung M-S, Kwon O-Y, Song W-J, Tatar M, Yu K. Minibrain/Dyrk1a regulates food intake through the Sir2-FOXO-sNPF/NPY pathway in Drosophila and mammals. PLoS Genet 2012; 8:e1002857; http://dx.doi.org/10.1371/journal.pgen.1002857; PMID: 22876196
   PubMedGoogle Scholar
• Johnson JD, Ahmed NT, Luciani DS, Han Z, Tran H, Fujita J, Misler S, Edlund H, Polonsky KS. Increased islet apoptosis in Pdx1+/- mice. J Clin Invest 2003; 111:1147 - 60; http://dx.doi.org/10.1172/JCI200316537; PMID: 12697734
   PubMed Web of Science ®Google Scholar
• Gao T, McKenna B, Li C, Reichert M, Nguyen J, Singh T, Yang C, Pannikar A, Doliba N, Zhang T, et al. Pdx1 maintains β cell identity and function by repressing an α cell program. Cell Metab 2014; 19:259 - 71; http://dx.doi.org/10.1016/j.cmet.2013.12.002; PMID: 24506867
   PubMed Web of Science ®Google Scholar
• Yang Y-P, Thorel F, Boyer DF, Herrera PL, Wright CVE. Context-specific α- to-β-cell reprogramming by forced Pdx1 expression. Genes Dev 2011; 25:1680 - 5; http://dx.doi.org/10.1101/gad.16875711; PMID: 21852533
   PubMed Web of Science ®Google Scholar
• Bernal-Mizrachi E, Fatrai S, Johnson JD, Ohsugi M, Otani K, Han Z, Polonsky KS, Permutt MA. Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells. J Clin Invest 2004; 114:928 - 36; http://dx.doi.org/10.1172/JCI200420016; PMID: 15467831
   PubMed Web of Science ®Google Scholar
• Bernal-Mizrachi E, Wen W, Stahlhut S, Welling CM, Permutt MA. Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J Clin Invest 2001; 108:1631 - 8; http://dx.doi.org/10.1172/JCI200113785; PMID: 11733558
   PubMed Web of Science ®Google Scholar
• Bernal-Mizrachi E, Cras-Méneur C, Ye BR, Johnson JD, Permutt MA. Transgenic overexpression of active calcineurin in beta-cells results in decreased beta-cell mass and hyperglycemia. PLoS One 2010; 5:e11969; http://dx.doi.org/10.1371/journal.pone.0011969; PMID: 20689817
   PubMedGoogle Scholar
• Heit JJ, Apelqvist AA, Gu X, Winslow MM, Neilson JR, Crabtree GR, Kim SK. Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function. Nature 2006; 443:345 - 9; http://dx.doi.org/10.1038/nature05097; PMID: 16988714
   PubMed Web of Science ®Google Scholar
• Wippich F, Bodenmiller B, Trajkovska MG, Wanka S, Aebersold R, Pelkmans L. Dual specificity kinase DYRK3 couples stress granule condensation/dissolution to mTORC1 signaling. Cell 2013; 152:791 - 805; http://dx.doi.org/10.1016/j.cell.2013.01.033; PMID: 23415227
   PubMed Web of Science ®Google Scholar
• Rachdi L, Balcazar N, Osorio-Duque F, Elghazi L, Weiss A, Gould A, Chang-Chen KJ, Gambello MJ, Bernal-Mizrachi E. Disruption of Tsc2 in pancreatic beta cells induces beta cell mass expansion and improved glucose tolerance in a TORC1-dependent manner. Proc Natl Acad Sci U S A 2008; 105:9250 - 5; http://dx.doi.org/10.1073/pnas.0803047105; PMID: 18587048
   PubMed Web of Science ®Google Scholar
• Rachdi L, Marie J-C, Scharfmann R. Role for VPAC2 receptor-mediated signals in pancreas development. Diabetes 2003; 52:85 - 92; http://dx.doi.org/10.2337/diabetes.52.1.85; PMID: 12502497
   PubMed Web of Science ®Google Scholar
• Rachdi L, Aïello V, Duvillié B, Scharfmann R. L-leucine alters pancreatic β-cell differentiation and function via the mTor signaling pathway. Diabetes 2012; 61:409 - 17; http://dx.doi.org/10.2337/db11-0765; PMID: 22210321
   PubMed Web of Science ®Google Scholar